
Granules India Q3 Results 2026 Highlights: Net Profit Rises by 27.73% & Revenue Up 22.00% YoY
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 28 Jan 2026 • 4:01 pm
Posted by:

Granules India Q3 Results FY26: During Q3 FY26, Granules India’s profit increased 27.73% YoY, while revenue increased by 22.00% YoY. The company posted robust numbers, with Q3 PAT at ₹150.21 crores and revenue at ₹1,387.94 crores. Granules India showed its Q3 results on 23rd January 2026.
Granules India Q3 Results FY26: Extracts of FY25 & FY26
| Particulars | Consolidated Figures | Standalone Figures | ||
| 31st Dec 2025 | 31st Dec 2024 | 31st Dec 2025 | 31st Dec 2024 | |
| Revenue from Operations | ₹1,387.94 | ₹1,137.70 | ₹895.32 | ₹842.20 |
| Profit Before Tax (PBT) | ₹304.46 | ₹235.97 | ₹206.36 | ₹173.48 |
| Profit After Tax (PAT) | ₹150.21 | ₹117.60 | ₹111.58 | ₹90.11 |
Granules India Q3 Results FY26 Highlights (Q3 FY26 vs FY25)
- Granules India clocked Q3 FY26 consolidated revenue of ₹1,387.94 crores vs ₹1,137.70 crores.
- On the profit front, Granules India earned a consolidated PAT of ₹150.21 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹117.60 crore.
- According to the consolidated figures, Granules India’s quarterly PAT increased by 27.73% YoY, while revenue increased by 22.00%.
- Granules India clocked Q3 FY26 standalone revenue of ₹895.32 crores vs ₹842.20 crores.
- On the profit front, Granules India earned a standalone PAT of ₹111.58 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹90.11 crore.
- According to the standalone figures, Granules India’s quarterly PAT increased by 23.83% YoY, while revenue increased by 6.31%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Granules India Share Price Performance
On the opening bell on 28th January 2026, Granules India shares opened at ₹579.05 per share. However, the initial gains have since eroded, and Granules India’s shares are currently trading at ₹564.90 per share, which is lower than the opening price.
Considering the long-term performance, Granules India shares have yielded returns of approximately 2.81% over the past year and 58.69% over the past 5 years. Over the maximum timeframe, Granules India shares delivered a 4,892.24% return to investors.
What Analysts Expect Post Q3 Results?
Following Granules India’s robust Q3 results for FY26, analysts expect its share price to rise. According to analysts, Granules India’s share price could reach ₹635.70 per share in the coming year and, in a downturn, could hit ₹549.10 per share. However, one must ignore stock market volatility and invest in Granules India’s shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Kanishk Aluminium India IPO GMP & Review: Apply or Avoid?
Msafe Equipments IPO GMP & Review: Apply or Avoid?
Union Budget 2026: What to Expect
The Indian Cements Q3 Results 2026 Highlights: Net Profit Falls by 102.18% & Revenue Up 18.56% YoY
Shriram Finance Q3 Results 2026 Highlights: Net Profit Falls by 22.09% & Revenue Up 13.76% YoY
CSB Bank Gears Up for Q3 Reveal on 28th January; Check Key Expectations Here
Recent Articles

Weekly Update- 30th May 2026
30 May 2026

Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
29 May 2026

Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
29 May 2026

Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights
29 May 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Weekly Update- 30th May 2026
Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights
Jetking Infotrain Q4 FY26 Results: Revenue Rs 4.67 Crore, Net Profit Rs 3.43 Crore and Key Highlights
Popular this week
Weekly Update- 30th May 2026
Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights
Jetking Infotrain Q4 FY26 Results: Revenue Rs 4.67 Crore, Net Profit Rs 3.43 Crore and Key Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





